Clinically,
temporal lobe epilepsy (TLE) is the most prevalent type of
partial epilepsy and often accompanied by various comorbidities. The present study aimed to evaluate the effects of chronic treatment with the
antiepileptic drug (AED)
lacosamide (LCM) on spontaneous
motor seizures (SMS), behavioral comorbidities, oxidative stress,
neuroinflammation, and neuronal damage in a model of TLE. Vehicle/LCM treatment (30 mg/kg, p.o.) was administered 3 h after the
pilocarpine-induced
status epilepticus (SE) and continued for up to 12 weeks in Wistar rats. Our study showed that LCM attenuated the number of SMS and corrected comorbid to
epilepsy impaired motor activity, anxiety, memory, and alleviated depressive-like responses measured in the elevated plus maze, object recognition test, radial arm maze test, and
sucrose preference test, respectively. This AED suppressed oxidative stress through increased
superoxide dismutase activity and
glutathione levels, and alleviated
catalase activity and lipid peroxidation in the hippocampus.
Lacosamide treatment after SE mitigated the increased levels of IL-1β and TNF-α in the hippocampus and exerted strong neuroprotection both in the dorsal and ventral hippocampus, basolateral amygdala, and partially in the piriform cortex. Our results suggest that the
antioxidant, anti-inflammatory, and neuroprotective activity of LCM is an important prerequisite for its
anticonvulsant and beneficial effects on SE-induced behavioral comorbidities.